Use of Anticancer Platinum Compounds in Combination Therapies and Challenges in Drug Delivery
Xiao Xiao1, James Trevor Oswald2, Ting Wang3
1School of Pharmacy, Jilin Medical University, Jilin, 132013, China.
Abstract:
As one of the leading and most important metal-based drugs, platinum-based pharmaceuticals are widely used in the treatment of solid malignancies. Despite significant side effects and acquired drug resistance have limited their clinical applications, platinum has shown strong inhibitory effects for a wide assortment of tumors. Drug delivery systems using emerging technologies such as liposomes, dendrimers, polymers, nanotubes and other nanocompositions, all show promise for the safe delivery of platinum-based compounds. Due to the specificity of nano-formulations; unwanted side-effects and drug resistance can be largely averted. In addition, combinational therapy has been shown to be an effective way to improve the efficacy of platinum based anti-tumor drugs. This review first introduces drug delivery systems used for platinum and combinational therapeutic delivery. Then we highlight some of the recent advances in the field of drug delivery for combinational therapy; specifically progress in leveraging the cytotoxic nature of platinum-based drugs, the combinational effect of other drugs with platinum, while evaluating the drug targeting, side effect reducing and sitespecific nature of nanotechnology-based delivery platforms.
Insights
Platinum-based drugs are crucial for cancer treatment but face challenges. Nanotechnology-based drug delivery systems offer a promising solution to improve efficacy and reduce side effects for platinum compounds.
Area of Science:
- Oncology
- Materials Science
- Nanotechnology
Background:
- Platinum-based drugs are vital chemotherapeutics for solid tumors.
- Clinical use is hindered by significant side effects and acquired drug resistance.
- Novel drug delivery systems are essential to overcome these limitations.
Purpose of the Study:
- To review current drug delivery systems for platinum-based compounds.
- To explore advancements in nanotechnology for platinum drug delivery.
- To evaluate combinational therapy strategies using platinum drugs.
Main Methods:
- Review of literature on platinum-based drug delivery systems.
- Analysis of nanotechnology applications (liposomes, dendrimers, polymers, nanotubes).
- Evaluation of combinational therapeutic approaches.
Main Results:
- Nanotechnology-based delivery systems show potential for targeted platinum delivery.
- Nano-formulations can mitigate unwanted side effects and drug resistance.
- Combinational therapy enhances the anti-tumor efficacy of platinum drugs.
Conclusions:
- Nanotechnology offers a promising platform for developing safer and more effective platinum-based cancer therapies.
- Targeted delivery and combinational strategies are key to improving treatment outcomes.
- Further research into nano-formulations can optimize platinum drug utilization.
More Related Videos
Related Concept Videos
Drug Therapy
Antianxiety Medications
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Molecules and Compounds
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Drug Delivery: Enteral Route


